Home > Offer to Sell > Pharmaceuticals and Biochemicals > Hormones and synthetic substitutes > Anti Breast Cancer Drug Fulvestrant 129453-61-8 with 99% Purity
Anti Breast Cancer Drug Fulvestrant 129453-61-8 with 99% Purity
Inquiry
| Post Date: | Dec 10,2016 |
| Expiry Date: | Dec 10,2017 |
| Detailed Description: |
Cas No. :129453-61-8
Quantity: 5Metric Tons Specs:USP Price:1 USD Metric Tons Payment Method: T/T, Western Union, Moneygram, Bitcoin Anti Breast Cancer Drug Fulvestrant 129453-61-8 with 99% Purity Description; Fulvestrant is known as a hormonal breast cancer treatment. It is used to treat advanced breast cancer and metastatic breast cancer. Advanced breast cancer is cancer which has progressed despite treatment, and metastatic breast cancer is cancer which has spread into other parts of the body. Many breast cancers need the female hormone oestrogen to grow. The cells of these cancers have tiny areas called receptors on their surface, which oestrogen can attach to. They are called 'hormone receptor-positive' cancers. Fulvestrant works by blocking the receptors and this prevents oestrogen from reaching the cancer cells. This slows the growth of the cancer. Specifications: Chemical Names: Fulvestrant; Faslodex; 129453-61-8; ICI 182,780; Ici 182780; ICI-182780 More... Molecular Formula: C32H47F5O3S Molecular Weight: 606.777 g/mol CAS:129453-61-8 Density:1.201 g/cm3 Melting Point:104-106°C Boiling Point: 674.8 °C at 760 mmHg Appearance: white powder Storage condition: 2-8°C Usage: Antineoplastic (hormonal) Uses: Fulvestrant is used to treat breast cancer that has spread to other areas of the body in women who have gone through "the change of life" (menopause). It is used in patients who have not responded well to other medications (e.g., tamoxifen). Breast cancer cells need the hormone estrogen in order to grow. Fulvestrant works by blocking the effect of estrogen, slowing tumor cell growth. How Fulvestrant Works： Many breast cancers are stimulated to grow by the female sex hormones oestrogen and progesterone. These breast cancers are called hormone sensitive or hormone receptor positive. Drugs that block the effects of these hormones can slow or stop the growth of the breast cancer cells. Fulvestrant stops oestrogen getting to the cancer cells by blocking oestrogen receptors and reducing the number of receptors the cancer cells have. What are the possible side effects of fulvestrant (Faslodex)? Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat. Less serious side effects may include: headache, back pain; bone pain, joint pain, muscle pain; vomiting, loss of appetite, constipation; weakness, feeling tired; cough, trouble breathing; pain in your arms or legs; hot flashes; or pain where the medicine was injected. Before taking fulvestrant tell your doctor and pharmacist if you are allergic to fulvestrant or any other medications. tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention anticoagulants (blood thinners) such as warfarin (Coumadin). Your doctor may need to change the doses of your medications or monitor you carefully for side effects. tell your doctor if you have or have ever had any bleeding problems or liver disease. you should know that fulvestrant should only be taken by women who have undergone menopause and cannot become pregnant. However, if you are pregnant, you should tell your doctor before you begin treatment with this medication. Your doctor may also check to see if you are pregnant before you begin treatment. Tell your doctor if you become pregnant during your treatment with fulvestrant. Fulvestrant may harm the fetus. tell your doctor if you are breast-feeding. You should not breast-feed during your treatment with fulvestrant. How this drug is given: As an injection into the muscle (intramuscular, IM). Fulvestrant is usually given as a once a month injection. Your doctor will determine any variations to this dosing or schedule. Usual Adult Dose for Breast Cancer: Initial dose: 500 mg IM on days 1, 15, and 29, then once a month thereafter. If you have any questions, pls feel free to contact me through below information： Email：debbie at chembj dot com WhatsApp:+8618872220738 |
| CAS Registry Number: | 129453-61-8 |
| Synonyms: | ;(7a,17b)-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol;(7alpha,17beta)-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1,3,5(10)-triene-3,17-diol;(17beta)-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1,3,5(10)-triene-3,17-diol;Faslodex; |
| Molecular Formula: | C32H47F5O3S |
| Molecular Weight: | 606.7708 |
| Molecular Structure: | 
|
| Company: | Wuhan Yuancheng Gongchuasng Technology Co.,Ltd [ China ] |
| Contact: | yuyalan |
| Tel: | +8618872220738 |
| Fax: | +86-27-68886696 |
| Email: | sales05c@ycphar.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
